Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients

Clinical trial NCT06046794 · RECRUITING

Trial details

NCT number: NCT06046794
Sponsor: Institut Paoli-Calmettes
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cancer Of Pancreas

Start date: 2024-05-23
Primary completion: 2027-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.